| | 144060-53-7 Basic information More.. |
| Product Name: | Febuxostat | | Synonyms: | Febuxostat (Uloric);Febuxostat (TEI-6720);Febuxostat Tablets;FEBUXOSTAT API;Febuxostat (This product is unavailable in the U.S.);Febuxostat Tabletshehe;Febuxostat
2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid;Febuxostat, >=99% | | CAS: | 144060-53-7 | | MF: | C16H16N2O3S | | MW: | 316.37 | | EINECS: | 682-158-6 | | Mol File: | 144060-53-7.mol |  |
Use
Febuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with gout. Hyperuricemia is defined as a serum uric acid concentration exceeding the limit of solubility. It predisposes affected persons to gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other tissues.
- Febuxostat
-
- US $0.00 / Kg/Bag
- 2024-04-22
- CAS:144060-53-7
- Min. Order: 2Kg/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
- Febuxostat
-
- US $6.00-5.00 / kg
- 2024-04-22
- CAS:144060-53-7
- Min. Order: 1kg
- Purity: 95%
- Supply Ability: 1000kg
- Febuxostat
-
- US $50.00 / kg
- 2024-04-18
- CAS:144060-53-7
- Min. Order: 1kg
- Purity: 99.10%
- Supply Ability: 50000kg
|
|
144060-53-7
Recommend Suppliers |
|